Certified by Founder Lodge
Luminopia
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $16,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA ap
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 29 ,2023 | Series A | $16,000,000 |
U.S. Venture Partners
ShangBay Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
CREAO AI | $10,000,000 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
ScreenPoint Medical | $14,000,000 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)
